Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: Mirror Image who wrote (1591)	12/17/2015 7:50:22 PM
From: OldBoar	Respond to of 2026

MI, Thanks, your research and insight are always appreciated. I had not noticed before and certainly was not aware of the ramping up of "open" purchase orders. I agree with you that these are goods or services that have not been received and paid for. What includes would be raw materials, reimbursing manufacturer, paying for ramp up of Fis study. But increasing at $2-3 m every quarter for last 3? I prefer related to manufacture of Vitaros due to demand. Otherwise, they certainly will need $ soon. Old Boar